Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Chitosan coated magnetic iron-oxide nanoparticles (CSMNPs) can be targeted to the tumor site under magnetic field and maintain
pH dependent drug release. Among various materials, chitosan has a great importance as a pH sensitive, natural, biodegradable,
biocompatible and bio-adhesive polymer. CSMNPs were in-situ synthesized at different sizes by ionic crosslinking method. XRD
and XPS analyses proved that synthesized iron-oxide was magnetite (Fe3O4). Chitosan coating on magnetite was detected by FTIR
and chitosan amount was 23% in TGA. CSMNPs were found super-paramagnetic by VSM. Average core size was 8 nm in TEM
and hydrodynamic diameter was 103 nm in DLS. The anti-cancer drug doxorubicin was loaded on CSMNPs (Dox-CSMNPs) and
loading was confirmed by FTIR. 30% of doxorubicin was released at pH 4.2 in first 7 hours. Dox-CSMNPs are efficiently taken up
by MCF-7 and 1 �¼M Doxorubicin resistant MCF-7 (MCF-7/Dox) breast cancer cells. CSMNPs increase the efficacy of Doxorubicin
by increasing the cellular uptake of drug and overcome the resistance of Doxorubicin in resistant cells. When these drugs are loaded
on CSMNPs, the anti-proliferative efficiencies of drugs increases and resistance to these drugs is eliminated. In vitro cytotoxicity
analyses also revealed that IC50 values of drug 13 fold decreases when loaded on CSMNPs. Pro-apoptotic Puma and Noxa genes were
up-regulated while anti-apoptotic Bcl-2, Survivin and cIAP-2 genes were down-regulated in Dox-CSMNP treated cells. This study
provides new insights to the development of pH responsive magnetic targeted drug delivery systems to overcome the side effects and
resistance problem of conventional chemotherapy.